{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T20:29:59Z","timestamp":1792873799559,"version":"4.5.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T00:00:00Z","timestamp":1708041600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001779","name":"Monash University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001779","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Addictive Behaviors"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.addbeh.2024.107988","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T21:25:29Z","timestamp":1708118729000},"page":"107988","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["A narrative systematic review of associations and temporality between use of methamphetamine, ecstasy\/MDMA, or cocaine with anxiety or depressive symptoms"],"prefix":"10.1016","volume":"153","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4003-7484","authenticated-orcid":false,"given":"Zoe","family":"Duncan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Kippen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Dietze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Sutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addbeh.2024.107988_b0005","unstructured":"Australian Institute of Health and Welfare (2020). National Drug Strategy Household Survey 2019. Drug Statistics series no. 32. PHE 270. Canberra AIHW."},{"key":"10.1016\/j.addbeh.2024.107988_b0010","doi-asserted-by":"crossref","unstructured":"Bao, A. M., & Swaab, D. F. (2019). The human hypothalamus in mood disorders: The HPA axis in the center. In IBRO Reports (Vol. 6, pp. 45\u201353). Elsevier Ltd. https:\/\/doi.org\/10.1016\/j.ibror.2018.11.008.","DOI":"10.1016\/j.ibror.2018.11.008"},{"issue":"3","key":"10.1016\/j.addbeh.2024.107988_b0015","article-title":"Probing the link between substance use and psychiatric disorders: toward a new paradigm in the treatment and prevention of these intertwined disorders","volume":"6","author":"Binder","year":"2023","journal-title":"International Journal of Psychiatry Research"},{"issue":"3\u20134","key":"10.1016\/j.addbeh.2024.107988_b0020","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/19371918.2013.774675","article-title":"Substance use disorders and anxiety: A treatment challenge for social workers","volume":"28","author":"Brady","year":"2013","journal-title":"Social Work in Public Health"},{"issue":"11","key":"10.1016\/j.addbeh.2024.107988_b0025","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1136\/jech-2011-200706","article-title":"Prospective associations between meth\/amphetamine (speed) and MDMA (ecstasy) use and depressive symptoms in secondary school students","volume":"66","author":"Bri\u00e8re","year":"2012","journal-title":"Journal of Epidemiology and Community Health"},{"key":"10.1016\/j.addbeh.2024.107988_b0030","first-page":"401","article-title":"Health outcomes associated with crack-cocaine use: Systematic review and meta-analyses","volume":"Vol. 180","author":"Butler","year":"2017"},{"issue":"3","key":"10.1016\/j.addbeh.2024.107988_b0035","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/QAI.0000000000002560","article-title":"Blue Monday: Co-occurring Stimulant Use and HIV Persistence Predict Dysregulated Catecholamine Synthesis","volume":"86","author":"Chahine","year":"2021","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"issue":"10","key":"10.1016\/j.addbeh.2024.107988_b0040","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1111\/add.15972","article-title":"Causal inference with observational data in addiction research","volume":"117","author":"Chan","year":"2022","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.addbeh.2024.107988_b0045","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.pop.2010.11.004","article-title":"Stimulant abuse: Pharmacology, cocaine, methamphetamine, treatment, attempts at pharmacotherapy","volume":"38","author":"Ciccarone","year":"2011","journal-title":"Primary care"},{"issue":"1\u20132","key":"10.1016\/j.addbeh.2024.107988_b0050","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.drugalcdep.2008.05.005","article-title":"Meta-analysis of depression and substance use and impairment among cocaine users","volume":"98","author":"Conner","year":"2008","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.addbeh.2024.107988_b0055","unstructured":"Covidence systematic review software, (2022). Veritas Health Innovation, Melbourne, Australia. Available at www.covidence.org."},{"issue":"3","key":"10.1016\/j.addbeh.2024.107988_b0060","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/09595230801923702","article-title":"Major physical and psychological harms of methamphetamine use","volume":"27","author":"Darke","year":"2008","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.addbeh.2024.107988_b0065","doi-asserted-by":"crossref","unstructured":"Dela Pe\u00f1a, I., Gevorkiana, R., & Shi, W. X. (2015). Psychostimulants affect dopamine transmission through both dopamine transporter-dependent and independent mechanisms. In European Journal of Pharmacology (Vol. 764, pp. 562\u2013570). Elsevier B.V. https:\/\/doi.org\/10.1016\/j.ejphar.2015.07.044.","DOI":"10.1016\/j.ejphar.2015.07.044"},{"issue":"8","key":"10.1016\/j.addbeh.2024.107988_b0070","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1177\/00048674211048152","article-title":"Correlates of anxiety and depression in a community cohort of people who smoke methamphetamine","volume":"56","author":"Duncan","year":"2021","journal-title":"Australian and New Zealand Journal of Psychiatry"},{"key":"10.1016\/j.addbeh.2024.107988_b0075","article-title":"Health Service Use for Mental Health Reasons in a Cohort of People Who Use Methamphetamine Experiencing Moderate to Severe Anxiety or Depression","author":"Duncan","year":"2022","journal-title":"International Journal of Mental Health and Addiction"},{"key":"10.1016\/j.addbeh.2024.107988_b0080","first-page":"1652","article-title":"Responding to global stimulant use: Challenges and opportunities","volume":"Vol. 394, No. 10209","author":"Farrell","year":"2019"},{"key":"10.1016\/j.addbeh.2024.107988_b0085","first-page":"344","article-title":"Directional Effects of Anxiety and Depressive Disorders with Substance Use: A Review of Recent Prospective Research","volume":"Vol. 7, No. 3","author":"Garey","year":"2020"},{"key":"10.1016\/j.addbeh.2024.107988_b0090","doi-asserted-by":"crossref","unstructured":"GBD 2016 Alcohol and Drug Use Collaborators (2018). The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. The lancet. Psychiatry, 5(12), 987\u20131012. https:\/\/doi.org\/10.1016\/S2215-0366(18)30337-7.","DOI":"10.1016\/S2215-0366(18)30337-7"},{"issue":"4","key":"10.1016\/j.addbeh.2024.107988_b0095","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00213-013-3132-7","article-title":"Ecstasy use and depression: A 4-year longitudinal study among an Australian general community sample","volume":"229","author":"George","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"issue":"7","key":"10.1016\/j.addbeh.2024.107988_b0100","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/jcop.21488","article-title":"Unanticipated effect of a randomized peer network intervention on depressive symptoms among young methamphetamine users in Thailand","volume":"40","author":"German","year":"2012","journal-title":"Journal of Community Psychology"},{"issue":"4","key":"10.1016\/j.addbeh.2024.107988_b0105","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/NMD.0b013e31819db6fe","article-title":"Depression among methamphetamine users: Association with outcomes from the methamphetamine treatment project at 3-year follow-up","volume":"197","author":"Glasner-Edwards","year":"2009","journal-title":"Journal of Nervous and Mental Disease"},{"issue":"1","key":"10.1016\/j.addbeh.2024.107988_b0110","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-020-01738-z","article-title":"Comorbidity between depression and anxiety: Assessing the role of bridge mental states in dynamic psychological networks","volume":"18","author":"Groen","year":"2020","journal-title":"BMC Medicine"},{"issue":"2","key":"10.1016\/j.addbeh.2024.107988_b0115","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s10461-015-1187-7","article-title":"Cocaine Use May be Associated with Increased Depression in Persons Infected with HIV","volume":"20","author":"Hammond","year":"2016","journal-title":"AIDS and Behavior"},{"key":"10.1016\/j.addbeh.2024.107988_b0120","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jsat.2016.08.011","article-title":"A Review of Methamphetamine Dependence and Withdrawal Treatment: A Focus on Anxiety Outcomes","volume":"71","author":"Hellem","year":"2016","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.addbeh.2024.107988_b0125","doi-asserted-by":"crossref","unstructured":"Hellem, T. L., Lundberg, K. J., & Renshaw, P. F. (2015). A review of treatment options for co-occurring methamphetamine use disorders and depression. In Journal of Addictions Nursing (Vol. 26, Issue 1, pp. 14\u201323). Lippincott Williams and Wilkins. https:\/\/doi.org\/10.1097\/JAN.0000000000000058.","DOI":"10.1097\/JAN.0000000000000058"},{"issue":"4","key":"10.1016\/j.addbeh.2024.107988_b0130","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1177\/1078390315598606","article-title":"The utility of magnetic resonance spectroscopy for understanding substance use disorders","volume":"21","author":"Hellem","year":"2015","journal-title":"Journal of the American Psychiatric Nurses Association"},{"key":"10.1016\/j.addbeh.2024.107988_b0135","author":"Hides","year":"2019","journal-title":"Psychological Interventions for Co-occurring Depression and Substance use Disorders (Review)"},{"key":"10.1016\/j.addbeh.2024.107988_b0140","series-title":"Principles of medical statistics","author":"Hill","year":"1991"},{"key":"10.1016\/j.addbeh.2024.107988_b0145","first-page":"234","article-title":"Prevalence of comorbid substance use in schizophrenia spectrum disorders in community and clinical settings, 1990\u20132017: Systematic review and meta-analysis","volume":"Vol. 191","author":"Hunt","year":"2018"},{"key":"10.1016\/j.addbeh.2024.107988_b0150","doi-asserted-by":"crossref","unstructured":"Hunt, G. E., Malhi, G. S., Lai, H. M. X., & Cleary, M. (2020). Prevalence of comorbid substance use in major depressive disorder in community and clinical settings, 1990\u20132019: Systematic review and meta-analysis. In Journal of Affective Disorders (Vol. 266, pp. 288\u2013304). Elsevier B.V. https:\/\/doi.org\/10.1016\/j.jad.2020.01.141.","DOI":"10.1016\/j.jad.2020.01.141"},{"issue":"5","key":"10.1016\/j.addbeh.2024.107988_b0155","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1017\/S003329172000272X","article-title":"Genetic correlation, pleiotropy, and causal associations between substance use and psychiatric disorder","volume":"52","author":"Jang","year":"2022","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.addbeh.2024.107988_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.107770","article-title":"Depressive symptoms and substance use: Changes overtime among a cohort of HIV-positive and HIV-negative MSM","volume":"207","author":"Javanbakht","year":"2020","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.addbeh.2024.107988_b0165","unstructured":"Joanna Briggs Institute. Critical appraisal tools (2017)."},{"issue":"1","key":"10.1016\/j.addbeh.2024.107988_b0170","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/02698811211058923","article-title":"MDMA\/ecstasy use and psilocybin use are associated with lowered odds of psychological distress and suicidal thoughts in a sample of US adults","volume":"36","author":"Jones","year":"2022","journal-title":"Journal of Psychopharmacology"},{"issue":"4","key":"10.1016\/j.addbeh.2024.107988_b0175","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/dar.12448","article-title":"A systematic review of the prevalence of comorbid mental health disorders in people presenting for substance use treatment in Australia","volume":"36","author":"Kingston","year":"2017","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.addbeh.2024.107988_b0180","first-page":"1","volume":"Vol. 154","author":"Lai","year":"2015","journal-title":"Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990\u20132014: A systematic review and meta-analysis"},{"issue":"2","key":"10.1016\/j.addbeh.2024.107988_b0185","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/15504263.2013.778930","article-title":"Relationships among depression, PTSD, methamphetamine abuse, and psychosis","volume":"9","author":"Lecomte","year":"2013","journal-title":"Journal of Dual Diagnosis"},{"issue":"1","key":"10.1016\/j.addbeh.2024.107988_b0190","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1108\/17570971211225145","article-title":"Examining the temporal relationship between methamphetamine use and mental health comorbidity","volume":"5","author":"Lee","year":"2012","journal-title":"Advances in Dual Diagnosis"},{"key":"10.1016\/j.addbeh.2024.107988_b0195","doi-asserted-by":"crossref","unstructured":"Leung, J., Mekonen, T., Wang, X. X., Arunogiri, S., Degenhardt, L., & McKetin, R. (2023). Methamphetamine exposure and depression\u2014A systematic review and meta-analysis. In Drug and Alcohol Review. John Wiley and Sons Inc. https:\/\/doi.org\/10.1111\/dar.13670.","DOI":"10.1111\/dar.13670"},{"issue":"4","key":"10.1016\/j.addbeh.2024.107988_b0200","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1017\/S0033291713001438","article-title":"The association between cannabis use and depression: A systematic review and meta-analysis of longitudinal studies","volume":"44","author":"Lev-Ran","year":"2014","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.addbeh.2024.107988_b0205","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jpsychires.2019.08.002","article-title":"Changes in the global burden of depression from 1990 to 2017: Findings from the Global Burden of Disease study","volume":"126","author":"Liu","year":"2020","journal-title":"Journal of Psychiatric Research"},{"key":"10.1016\/j.addbeh.2024.107988_b0210","doi-asserted-by":"crossref","unstructured":"Manetti, L., Cavagnini, F., Martino, E., & Ambrogio, A. (2014). Effects of cocaine on the hypothalamic-pituitary-adrenal axis. In Journal of Endocrinological Investigation (Vol. 37, Issue 8, pp. 701\u2013708). Springer International Publishing. https:\/\/doi.org\/10.1007\/s40618-014-0091-8.","DOI":"10.1007\/s40618-014-0091-8"},{"issue":"6","key":"10.1016\/j.addbeh.2024.107988_b0215","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/j.1360-0443.2010.02932.x","article-title":"Health outcomes associated with methamphetamine use among young people: A systematic review","volume":"105","author":"Marshall","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.addbeh.2024.107988_b0220","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.psychres.2016.02.038","article-title":"Correlates of transient versus persistent psychotic symptoms among dependent methamphetamine users","volume":"238","author":"McKetin","year":"2016","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.addbeh.2024.107988_b0225","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.eclinm.2019.09.014","article-title":"Mental health outcomes associated with of the use of amphetamines: A systematic review and meta-analysis","volume":"16","author":"McKetin","year":"2019","journal-title":"EClinicalMedicine"},{"issue":"7","key":"10.1016\/j.addbeh.2024.107988_b0230","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1007\/s10461-017-1801-y","article-title":"Longitudinal Modeling of Depressive Trajectories Among HIV-Infected Men Using Cocaine","volume":"21","author":"Mukerji","year":"2017","journal-title":"AIDS and Behavior"},{"issue":"3","key":"10.1016\/j.addbeh.2024.107988_b0235","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pneurobio.2007.01.001","article-title":"Serotonin and psychostimulant addiction: Focus on 5-HT1A-receptors","volume":"81","author":"M\u00fcller","year":"2007","journal-title":"In Progress in Neurobiology (Vol."},{"key":"10.1016\/j.addbeh.2024.107988_b0240","doi-asserted-by":"crossref","unstructured":"Nuttbrock, L., Bockting, W., Rosenblum, A., Hwahng, S., Mason, M., Macri, M., & Becker, J. (2014). Gender Abuse, Depressive Symptoms, and Substance Use Among Transgender Women: A 3-Year Prospective Study. American Journal of Public Health Nuttbrock et al. | Peer Reviewed | Research and Practice, 104(11), 2199. https:\/\/doi.org\/10.2105\/AJPH.2014.","DOI":"10.2105\/AJPH.2014.302106"},{"issue":"71","key":"10.1016\/j.addbeh.2024.107988_b0245","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.addbeh.2024.107988_b0250","doi-asserted-by":"crossref","unstructured":"Paiva, C., Ferreira, I., Bosa, V., & Narvaez, J. (2017). Depression, anxiety, hopelessness and quality of life in users of cocaine\/crack in outpatient treatment. Trends in Psychiatry and Psychotherapy, 39(1), 34\u201342. https:\/\/doi.org\/10.1590\/2237-6089-2015-0065APRS.","DOI":"10.1590\/2237-6089-2015-0065"},{"issue":"3","key":"10.1016\/j.addbeh.2024.107988_b0255","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s11920-012-0264-0","article-title":"Exploring the comorbidity of anxiety and substance use disorders","volume":"14","author":"Pasche","year":"2012","journal-title":"Current Psychiatry Reports"},{"key":"10.1016\/j.addbeh.2024.107988_b0260","doi-asserted-by":"crossref","unstructured":"Paulus, M. P., & Stewart, J. L. (2020). Neurobiology, clinical presentation, and treatment of methamphetamine use disorder: A review. In JAMA Psychiatry (Vol. 77, Issue 9, pp. 959\u2013966). American Medical Association. https:\/\/doi.org\/10.1001\/jamapsychiatry.2020.0246.","DOI":"10.1001\/jamapsychiatry.2020.0246"},{"issue":"9","key":"10.1016\/j.addbeh.2024.107988_b0265","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1007\/s10461-018-2147-9","article-title":"Mood, Meth, Condom Use, and Gender: Latent Growth Curve Modeling Results from a Randomized Trial","volume":"22","author":"Pitpitan","year":"2018","journal-title":"AIDS and Behavior"},{"key":"10.1016\/j.addbeh.2024.107988_b0270","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jad.2017.06.017","article-title":"Brain-derived neurotrophic factor levels and depression during methamphetamine withdrawal","volume":"221","author":"Ren","year":"2017","journal-title":"Journal of Affective Disorders"},{"issue":"4","key":"10.1016\/j.addbeh.2024.107988_b0275","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/ajr.12331","article-title":"Ice and the outback: Patterns and prevalence of methamphetamine use in rural Australia","volume":"25","author":"Roche","year":"2017","journal-title":"Australian Journal of Rural Health"},{"key":"10.1016\/j.addbeh.2024.107988_b0280","doi-asserted-by":"crossref","unstructured":"Rogers, A. H., Zvolensky, M. J., Ditre, J. W., Buckner, J. D., & Asmundson, G. J. G. (2021). Association of opioid misuse with anxiety and depression: A systematic review of the literature. In Clinical Psychology Review (Vol. 84). Elsevier Inc. https:\/\/doi.org\/10.1016\/j.cpr.2021.101978.","DOI":"10.1016\/j.cpr.2021.101978"},{"issue":"8","key":"10.1016\/j.addbeh.2024.107988_b0285","doi-asserted-by":"crossref","first-page":"e029476","DOI":"10.1136\/bmjopen-2019-029476","article-title":"Understanding pathways to stimulant use: A mixed-methods examination of the individual, social and cultural factors shaping illicit stimulant use across Europe (ATTUNE): Study protocol","volume":"9","author":"Rosenkranz","year":"2019","journal-title":"BMJ Open"},{"issue":"12","key":"10.1016\/j.addbeh.2024.107988_b0290","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1177\/0004867412461057","article-title":"Stimulant use disorders: Characteristics and comorbidity in an Australian population sample","volume":"46","author":"Sara","year":"2012","journal-title":"Australian and New Zealand Journal of Psychiatry"},{"issue":"s19","key":"10.1016\/j.addbeh.2024.107988_b0295","doi-asserted-by":"crossref","first-page":"113","DOI":"10.15288\/jsads.2020.s19.113","article-title":"The relationship between exposure to alcohol marketing and underage drinking is causal","volume":"2020","author":"Sargent","year":"2020","journal-title":"Journal of Studies on Alcohol and Drugs"},{"key":"10.1016\/j.addbeh.2024.107988_b0300","doi-asserted-by":"crossref","unstructured":"Savic, M., Best, D., Manning, V., & Lubman, D. I. (2017). Strategies to facilitate integrated care for people with alcohol and other drug problems: A systematic review. In Substance Abuse: Treatment, Prevention, and Policy (Vol. 12, Issue 1). BioMed Central Ltd. https:\/\/doi.org\/10.1186\/s13011-017-0104-7.","DOI":"10.1186\/s13011-017-0104-7"},{"key":"10.1016\/j.addbeh.2024.107988_b0305","doi-asserted-by":"crossref","unstructured":"Sheng, J. A., Bales, N. J., Myers, S. A., Bautista, A. I., Roueinfar, M., Hale, T. M., & Handa, R. J. (2021). The Hypothalamic-Pituitary-Adrenal Axis: Development, Programming Actions of Hormones, and Maternal-Fetal Interactions. In Frontiers in Behavioral Neuroscience (Vol. 14). Frontiers Media S.A. https:\/\/doi.org\/10.3389\/fnbeh.2020.601939.","DOI":"10.3389\/fnbeh.2020.601939"},{"key":"10.1016\/j.addbeh.2024.107988_b0310","doi-asserted-by":"crossref","unstructured":"Siefried, K. J., Acheson, L. S., Lintzeris, N., & Ezard, N. (2020). Pharmacological Treatment of Methamphetamine\/Amphetamine Dependence: A Systematic Review. In CNS Drugs (Vol. 34, Issue 4, pp. 337\u2013365). Adis. https:\/\/doi.org\/10.1007\/s40263-020-00711-x.","DOI":"10.1007\/s40263-020-00711-x"},{"key":"10.1016\/j.addbeh.2024.107988_b0315","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.drugpo.2019.05.023","article-title":"Integrated models of care for people who inject drugs and live with hepatitis C virus: A systematic review","volume":"72","author":"Soc\u00edas","year":"2019","journal-title":"International Journal of Drug Policy"},{"issue":"108059","key":"10.1016\/j.addbeh.2024.107988_b0320","first-page":"1","article-title":"Oxytocin-enhanced group therapy for methamphetamine use disorder: Randomized controlled trial","volume":"116","author":"Stauffer","year":"2020","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.addbeh.2024.107988_b0325","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.drugalcdep.2018.10.029","article-title":"Using a data science approach to predict cocaine use frequency from depressive symptoms","volume":"194","author":"Suchting","year":"2019","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.addbeh.2024.107988_b0330","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1177\/0269881105048901","article-title":"Self-reported depressive symptomatology in community samples of polysubstance misusers who report Ecstasy use: A meta-analysis","volume":"19","author":"Sumnall","year":"2005","journal-title":"In Journal of Psychopharmacology (Vol."},{"key":"10.1016\/j.addbeh.2024.107988_b0335","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.drugpo.2018.08.015","article-title":"Quantifying the societal cost of methamphetamine use to Australia","volume":"62","author":"Tait","year":"2018","journal-title":"International Journal of Drug Policy"},{"issue":"4","key":"10.1016\/j.addbeh.2024.107988_b0340","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/dar.13196","article-title":"The prevalence of mental health disorders among young adults who use amphetamine-type stimulants, compared to young adults who do not","volume":"40","author":"Thoradeniya","year":"2021","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.addbeh.2024.107988_b0345","doi-asserted-by":"crossref","unstructured":"Turner, S., Mota, N., Bolton, J., & Sareen, J. (2018). Self-medication with alcohol or drugs for mood and anxiety disorders: A narrative review of the epidemiological literature. In Depression and Anxiety (Vol. 35, Issue 9, pp. 851\u2013860). Blackwell Publishing Inc. https:\/\/doi.org\/10.1002\/da.22771.","DOI":"10.1002\/da.22771"},{"issue":"10258","key":"10.1016\/j.addbeh.2024.107988_b0350","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: A systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Vos","year":"2020","journal-title":"The Lancet"},{"key":"10.1016\/j.addbeh.2024.107988_b0355","doi-asserted-by":"crossref","unstructured":"Vujanovic, A. A., Meyer, T. D., Heads, A. M., Stotts, A. L., Villarreal, Y. R., & Schmitz, J. M. (2017). Cognitive-behavioral therapies for depression and substance use disorders: An overview of traditional, third-wave, and transdiagnostic approaches. In American Journal of Drug and Alcohol Abuse (Vol. 43, Issue 4, pp. 402\u2013415). Taylor and Francis Ltd. https:\/\/doi.org\/10.1080\/00952990.2016.1199697.","DOI":"10.1080\/00952990.2016.1199697"},{"issue":"7","key":"10.1016\/j.addbeh.2024.107988_b0360","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/s00213-013-3325-0","article-title":"Basal functioning of the hypothalamic-pituitary-adrenal (HPA) axis and psychological distress in recreational ecstasy polydrug users","volume":"231","author":"Wetherell","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.addbeh.2024.107988_b0365","article-title":"World mental health report: Transforming mental health for all","author":"World Health Organisation","year":"2022","journal-title":"World Mental Health Report"},{"key":"10.1016\/j.addbeh.2024.107988_b0370","doi-asserted-by":"crossref","DOI":"10.1017\/S2045796021000275","article-title":"Global, regional and national burden of anxiety disorders from 1990 to 2019: Results from the Global Burden of Disease Study 2019","author":"Yang","year":"2021","journal-title":"Epidemiology and Psychiatric Sciences"},{"issue":"MAY","key":"10.1016\/j.addbeh.2024.107988_b0380","first-page":"178","article-title":"Methamphetamine and the hypothalamic-pituitary-adrenal axis","volume":"9","author":"Zuloaga","year":"2015","journal-title":"Frontiers in Neuroscience"}],"container-title":["Addictive Behaviors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306460324000376?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306460324000376?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T18:55:55Z","timestamp":1759690555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306460324000376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":75,"alternative-id":["S0306460324000376"],"URL":"https:\/\/doi.org\/10.1016\/j.addbeh.2024.107988","relation":{},"ISSN":["0306-4603"],"issn-type":[{"value":"0306-4603","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A narrative systematic review of associations and temporality between use of methamphetamine, ecstasy\/MDMA, or cocaine with anxiety or depressive symptoms","name":"articletitle","label":"Article Title"},{"value":"Addictive Behaviors","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addbeh.2024.107988","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107988"}}